New York Life Investment Management »

Beam Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $355k 11k 33.04

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Beam Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
FMR
Farallon Capital Management
Morgan Stanley
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Darwin Global Management
Redmile Group
Geode Capital Management
T. Rowe Price Associates
Bellevue Group
Yiheng Capital
Baillie Gifford & Co

View all funds holding Beam Therapeutics